Susquehanna International Group
SKYE icon

Susquehanna International Group’s Skye Bioscience SKYE Stock Holding History

Susquehanna International Group’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,592
Closed -$113K – 13851
2025
Q3 		$113K Sell
3,592
-5,623
-61% -$170K ﹤0.01% 11487
2025
Q2 		$308K Buy
9,215
+5,043
+121% +$83.5K ﹤0.01% 10276
2025
Q1 		$53.1K Buy
4,172
+2,128
+104% +$46.5K ﹤0.01% 11839
2024
Q4 		$46.3K Buy
2,044
+132
+7% +$4.41K ﹤0.01% 11710
2024
Q3 		$59.8K Buy
+1,912
New +$85.8K ﹤0.01% 11310

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Schonfeld Strategic Advisors
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Susquehanna International Group's SKYE Position: Q4 2025 in Review

Susquehanna International Group sold out of Skye Bioscience (SKYE) in Q4 2025, closing a stake of 3,592 shares — an estimated $113K sold.

Susquehanna International Group first reported a position in SKYE in Q3 2024 and held it in 5 quarters. The position peaked at $308K in Q2 2025. 42 funds tracked by Wall St. Rank hold SKYE as of Q4 2025.

  • Susquehanna International Group reported no remaining Skye Bioscience position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 3,592 Skye Bioscience shares in Q4 2025, an estimated $113K.
  • Susquehanna International Group first reported a position in Skye Bioscience in Q3 2024 and held it in 5 quarters.
  • Susquehanna International Group's Skye Bioscience position peaked at $308K in Q2 2025.
  • 42 funds tracked by Wall St. Rank held Skye Bioscience as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.